Clicky

Organon & Co(7XP) News

Date Title
Jul 2 Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain
Jun 27 Organon (OGN) Stock Sinks As Market Gains: What You Should Know
Jun 26 5 Must-Read Analyst Questions From Organon’s Q1 Earnings Call
Jun 17 All You Need to Know About Organon (OGN) Rating Upgrade to Buy
Jun 17 OGN or DOCS: Which Is the Better Value Stock Right Now?
Mar 28 European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11
Mar 8 New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older
Feb 15 Organon Full Year 2024 Earnings: EPS Misses Expectations
Feb 13 Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024